Clinical trialNCT04120987WithdrawnPhase 4Interventional

Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra

SponsorBucci Laser Vision InstituteEnrollment0Dry Eye

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To determine if the use of Xiidra® reduces ocular surface inflammation in preoperative and postoperative cataract patients.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Frank A Bucci, Jr., MD
Bucci Laser Vision
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Bucci Laser Vision
Wilkes-Barre, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Lifitegrast 5% Ophthalmic Solution

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2021
Primary completion: 25 Jun 2022
Completion: 25 Jun 2022
Last update posted: 27 Jul 2023
Registered enrollment: 0
Registry id: NCT04120987

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.